Cyclo Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| EPIQ CAPITAL GROUP, LLC | 02/07/2025 | 689.45 K | $406.77 K | -6.76% | 2.40% |
| VANGUARD GROUP INC | 02/11/2025 | 598.69 K | $353.23 K | 0.00% | 2.08% |
| FOUNDERS FUND V MANAGEMENT, LLC | 02/14/2025 | 480.71 K | $283.62 K | 0.00% | 1.67% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 152.33 K | $89.91 K | 0.00% | 0.53% |
| BLACKROCK, INC. | 02/07/2025 | 83.82 K | $49.46 K | 0.36% | 0.29% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 42.54 K | $25.10 K | 100.00% | 0.15% |
| STATE STREET CORP | 02/14/2025 | 39.53 K | $23.32 K | 0.00% | 0.14% |
| NORTHERN TRUST CORP | 02/14/2025 | 21.74 K | $12.82 K | 0.06% | 0.08% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 03/17/2025 | 18.29 K | $10.79 K | -21.86% | 0.06% |
| UBS GROUP AG | 02/14/2025 | 11.99 K | $7.07 K | -3.78% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 6.68 K | $3.94 K | 23.89% | 0.02% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 4.39 K | $2.59 K | 0.00% | 0.02% |
| MORGAN STANLEY | 05/15/2025 | 1.03 K | $608 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/12/2025 | 193 | $114 | -0.52% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 170 | $100 | -82.90% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/06/2025 | 90 | $53 | 0.00% | 0.00% |
| FMR LLC | 02/13/2025 | 30 | $18 | 100.00% | 0.00% |
| 02/06/2025 | 11 | $6 | 100.00% | 0.00% | |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 1 | $1 | 100.00% | 0.00% |
| ROYAL BANK OF CANADA | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| PRINCETON GLOBAL ASSET MANAGEMENT LLC | 01/24/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cyclo Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 18 institutional investors and hedge funds held shares of Cyclo Therapeutics, Inc.. The most heavily invested institutionals were:
JPMORGAN CHASE & CO: 0
STATE STREET CORP: 0
BNP PARIBAS ARBITRAGE, SNC: 0
WELLS FARGO & COMPANY/MN: 0
MORGAN STANLEY: 0
TWO SIGMA SECURITIES, LLC: 0
7.49% of Cyclo Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 748.96 K shares in the last 24 months. This purchase volume represents approximately $0 in transactions.